On Tuesday, in the course of current trade, Shares of Advanced Micro Devices, Inc.(NASDAQ:AMD), climbed 3.83%, and is now trading at $2.04.
Advanced Micro Devices, declared its new AMD Catalyst 15.7 Driver update delivering seamless and intuitive support for Windows 10 and the DirectX 12 API, and is a primary ingredient for users to get the most out of their AMD APU and GPU solutions.
The AMD Catalyst 15.7 driver is a foundational driver that will assist enrich the user experience through more reliable performance, innovative features and technologies. The AMD Catalyst driver will be fully integrated with Microsoft Windows 10 as part of the Windows driver update component.
Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. The company’s products primarily comprise x86 microprocessors as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs), and semi-custom System-on-Chip (SoC) products.
During an Afternoon trade, Shares of Qiagen NV (NASDAQ:QGEN), raised 0.80%, and is now trading at $26.44.
Qiagen , received U.S. marketing (PMA) approval of its therascreen EGFR RGQ PCR Kit (therascreen EGFR test) as a companion diagnostic to guide the use of AstraZeneca’s IRESSA (gefitinib) in the treatment of patients with advanced or metastatic non-small cell lung cancer (NSCLC). QIAGEN’s therascreen EGFR test was approved by the Food and Drug Administration to enable doctors to identify NSCLC patients who have tumors that are positive for epidermal growth factor receptor (EGFR) mutations and therefore are eligible for treatment with AstraZeneca’s drug.
More than 200,000 new lung cancer cases are diagnosed every year in the United States, with NSCLC accounting for about 85% of cases, leading to an estimated 160,000 deaths. Testing for EGFR mutations is believed to be the largest segment in companion diagnostics for personalized medicine.
QIAGEN N.V. provides sample to insight solutions that transform biological samples into valuable molecular insights worldwide. It offers sample technologies to isolate, purify, and stabilize nucleic acids and proteins in plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, and library preparation for sequencing applications; and assay technologies to detect molecular targets.
Finally, Sensata Technologies Holding N.V.(NYSE:ST), gained 0.12% Tuesday, hitting its highest level.
Sensata Technologies Holding, will issue a press release announcing its financial results for the second quarter ended June 30, 2015 on Tuesday, July 28, 2015.
Sensata will conduct a conference call on the same day at 8:00 a.m. Eastern Time to talk about the results.
Sensata Technologies Holding N.V., through its auxiliaries, develops, manufactures, and sells sensors and controls. It operates in two segments, Sensors and Controls. The Sensors segment manufactures pressure, temperature, speed, position, and force sensors, in addition to electromechanical sensors.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
